How do you feel about gene therapy like AMT-130 being used to treat Huntington’s disease?
Gene Therapy Breakthrough Offers New Hope for Huntington’s Disease Patients
Huntington’s disease, a fatal inherited neurological condition, has seen its first major therapeutic breakthrough in decades. In September 2025, researchers announced that a gene therapy called AMT-130 slowed progression by nearly 75% in some patients over a 3-year period. The therapy works by delivering DNA into the brain to reduce production of the mutant huntingtin protein responsible for HD symptoms. Though the treatment requires invasive neurosurgery and is not yet widely available, scientists and patient advocacy groups are calling it a historic step forward. Parallel research into other treatments like SKY-0515 and allele-specific gene editing also offers new promise. This breakthrough raises questions about accessibility, cost, and the ethics of manipulating genetic code, but it’s being hailed as a turning point in the fight against neurodegenerative disease.
Options
- It’s a major medical breakthrough
- Too experimental for widespread use
- Ethical concerns about gene editing
- Encouraging, but still early days
- Not sure